Review
Version 1
Preserved in Portico This version is not peer-reviewed
Endometriosis, Oocyte and Embryo Quality
Version 1
: Received: 6 June 2023 / Approved: 7 June 2023 / Online: 7 June 2023 (03:25:39 CEST)
A peer-reviewed article of this Preprint also exists.
Latif, S.; Saridogan, E. Endometriosis, Oocyte, and Embryo Quality. J. Clin. Med. 2023, 12, 4186. Latif, S.; Saridogan, E. Endometriosis, Oocyte, and Embryo Quality. J. Clin. Med. 2023, 12, 4186.
Abstract
Endometriosis is a common finding among women with infertility and women who are diag-nosed with endometriosis are almost twice as likely to experience infertility. Mechanisms by which endometriosis causes infertility remain poorly understood. In this review we evaluate the current literature on the impact of endometriosis on oocyte and embryo quality. The presence of endometriosis evidently reduces ovarian reserve, oocyte quality and embryo quality, however this does not appear to translate to a clear clinical impact. Analysis of data from large assisted reproduction technology registries has shown that women with endometriosis have a lower oo-cyte yield but no reduction in reproductive outcomes. There is a need for future studies in the form of well-designed randomised controlled trials to further evaluate the role of surgical and medi-cal treatment options in women with endometriosis undergoing assisted conception.
Keywords
Endometriosis; in vitro fertilization; oocytes; embryonic structures
Subject
Medicine and Pharmacology, Obstetrics and Gynaecology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
